Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

Tag: Emerging markets GMP standards

How to Ensure GMP Compliance for Pharmaceuticals Produced in the EU

Posted on February 6, 2025 By digi

How to Ensure GMP Compliance for Pharmaceuticals Produced in the EU A Comprehensive Guide to GMP Compliance for Pharmaceutical Manufacturing in the EU Introduction to GMP Compliance in the EU Pharmaceutical manufacturing in the European Union (EU) is governed by stringent Good Manufacturing Practices (GMP) to ensure product quality, safety, and efficacy. Enforced by the…

Read More “How to Ensure GMP Compliance for Pharmaceuticals Produced in the EU” »

GMP in Europe (EMA, MHRA)

The Impact of Schedule M Revised on Indian Pharmaceutical R&D and Drug Development

Posted on February 6, 2025 By digi

The Impact of Schedule M Revised on Indian Pharmaceutical R&D and Drug Development How Schedule M Revised Influences Pharmaceutical R&D and Drug Development in India Introduction to Schedule M Revised and Its Relevance to R&D Research and Development (R&D) is the cornerstone of innovation in the pharmaceutical industry, driving the discovery and development of new…

Read More “The Impact of Schedule M Revised on Indian Pharmaceutical R&D and Drug Development” »

GMP in India

How to Leverage Technology for GMP Compliance in Latin America

Posted on February 6, 2025 By digi

How to Leverage Technology for GMP Compliance in Latin America A Step-by-Step Guide to Using Technology for GMP Compliance in Latin America Introduction to GMP Compliance and Technology Achieving Good Manufacturing Practices (GMP) compliance is essential for pharmaceutical manufacturers in Latin America, where regulatory frameworks like those established by ANVISA in Brazil and Cofepris in…

Read More “How to Leverage Technology for GMP Compliance in Latin America” »

GMP in Emerging Markets (GCC, Latin America, Africa)

How to Maintain GMP Compliance During the Scaling-Up Process in Pharma Manufacturing

Posted on February 6, 2025 By digi

How to Maintain GMP Compliance During the Scaling-Up Process in Pharma Manufacturing Expert Guide to Ensuring GMP Compliance in Pharmaceutical Scale-Up Processes Introduction to GMP Compliance in Scale-Up Scaling up pharmaceutical manufacturing involves transitioning from laboratory-scale production to commercial-scale operations. While this process is essential for meeting market demand, it presents unique challenges in maintaining…

Read More “How to Maintain GMP Compliance During the Scaling-Up Process in Pharma Manufacturing” »

GMP in Europe (EMA, MHRA)

Best Tools for Ensuring GMP Compliance in the GCC Pharmaceutical Sector

Posted on February 6, 2025 By digi

Best Tools for Ensuring GMP Compliance in the GCC Pharmaceutical Sector Essential Tools for Achieving GMP Compliance in the GCC Pharmaceutical Industry Introduction to GMP Compliance in the GCC The Gulf Cooperation Council (GCC) region has seen significant growth in its pharmaceutical sector, driven by increased demand for high-quality medicines and stringent regulatory requirements. Achieving…

Read More “Best Tools for Ensuring GMP Compliance in the GCC Pharmaceutical Sector” »

GMP in Emerging Markets (GCC, Latin America, Africa)

How Schedule M Revised Supports the Use of Automation and Technology in GMP Compliance

Posted on February 6, 2025 By digi

How Schedule M Revised Supports the Use of Automation and Technology in GMP Compliance Enhancing GMP Compliance Through Automation and Technology Under Schedule M Revised Introduction to Automation, Technology, and Schedule M Revised The revised Schedule M under the Drugs and Cosmetics Rules, 1945, emphasizes Good Manufacturing Practices (GMP) to ensure the safety, efficacy, and…

Read More “How Schedule M Revised Supports the Use of Automation and Technology in GMP Compliance” »

GMP in India

How MHRA’s GMP Guidelines Apply to Clinical Trials and Drug Manufacturing

Posted on February 5, 2025 By digi

How MHRA’s GMP Guidelines Apply to Clinical Trials and Drug Manufacturing A Step-by-Step Guide to MHRA’s GMP Guidelines for Clinical Trials and Drug Manufacturing Introduction to MHRA GMP Guidelines The Medicines and Healthcare products Regulatory Agency (MHRA) oversees the implementation of Good Manufacturing Practices (GMP) in the UK to ensure the safety, quality, and efficacy…

Read More “How MHRA’s GMP Guidelines Apply to Clinical Trials and Drug Manufacturing” »

GMP in Europe (EMA, MHRA)

How to Implement a Quality Management System (QMS) for GMP Compliance in Emerging Markets

Posted on February 5, 2025 By digi

How to Implement a Quality Management System (QMS) for GMP Compliance in Emerging Markets A Step-by-Step Guide to Implementing a QMS for GMP Compliance in Emerging Markets Introduction to QMS and GMP Compliance A Quality Management System (QMS) is the backbone of any successful pharmaceutical manufacturing operation, ensuring adherence to Good Manufacturing Practices (GMP). In…

Read More “How to Implement a Quality Management System (QMS) for GMP Compliance in Emerging Markets” »

GMP in Emerging Markets (GCC, Latin America, Africa)

How Schedule M Revised Supports GMP Compliance for Clinical Trials in India

Posted on February 5, 2025 By digi

How Schedule M Revised Supports GMP Compliance for Clinical Trials in India A Guide to Ensuring GMP Compliance for Clinical Trials Under Schedule M Revised Introduction to Schedule M Revised and Clinical Trials Clinical trials are a critical phase in the development of pharmaceutical products, requiring stringent adherence to Good Manufacturing Practices (GMP) to ensure…

Read More “How Schedule M Revised Supports GMP Compliance for Clinical Trials in India” »

GMP in India

Best Practices for Preventing Cross-Contamination in GMP Pharmaceutical Facilities

Posted on February 5, 2025 By digi

Best Practices for Preventing Cross-Contamination in GMP Pharmaceutical Facilities Effective Strategies to Prevent Cross-Contamination in GMP-Compliant Pharmaceutical Facilities Introduction to Cross-Contamination and GMP Cross-contamination in pharmaceutical manufacturing can compromise product quality, endanger patient safety, and result in regulatory non-compliance. To mitigate these risks, Good Manufacturing Practices (GMP), as enforced by regulatory bodies like the European…

Read More “Best Practices for Preventing Cross-Contamination in GMP Pharmaceutical Facilities” »

GMP in Europe (EMA, MHRA)

Posts pagination

Previous 1 … 12 13 14 … 26 Next

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme